Accreditations

About Us

National/International Accreditations
AXIS Clinicals has been audited and approved by various regulatory authorities that include:

Drugs Controller General of India
USFDA
EMEA
MHRA
AFSSAPS, France
ANVISA, Brazil
MCC, South Africa
MOH, Turkey
MOH, Mexico
Thailand FDA
WHO
GCC-DR ( Gulf Central Committee for Drug Registration)

Medical Diagnostic Lab of AXIS Clinicals has been approved and accredited by NABL on annual basis. Besides study submissions to more than 25 countries, AXIS Clinicals has also been approved for submission of studies to MOH Canada, NPCB Malaysia, Australia, South Africa and WHO.

Fact sheet

2,600+ clinical studies completed since inception
350+ bioanalytical methods developed
50+ successful Regulatory audits
Global footprint of operations with sites in India, U.S & Mexico.
Two clinical facilities (Hyderabad & Ahmedabad) in India
100+ National and International Pharma/Biotech Sponsor companies working with AXIS
US FDA : 500+ approvals, EMEA : 100+ approvals, Canada : 50+ approvals, Australia : 50+ approvals
500+ experienced employees working globally
Huge database of patient population in various therapeutic areas viz. Cardiology, Opthalmology, Schizophrenia, Diabetology, Oncology. Orthopedics etc..